Medpac.gov Website Review

> is a nonpartisan legislative branch agency that provides the u.s. > congress with an*lysis and policy advice on the medicare program.. medpac comment on cms's plan to add product categories to the dmepos competitive bidding program. medpac comment on cms's proposed rule on requiring drug pricing transparency. medpac comment on cms's proposed rule on medicare shared savings program acos. medpac comment on cms's proposed rule on hospital outpatient and ambulatory surgical center payment systems for cy 2019. medpac comment on cms's proposed rule on the physician fee schedule and other revisions to part b for cy 2019. medpac comment on cms's proposed rule on the esrd pps update for cy 2019 and dmepos competitive bidding program. medpac comment on cms's proposed rule on the cy 2019 home health pps update and 2020 case mix refinements. medpac comment on hhs's policy statement and rfi on the hhs blueprint to lower drug prices and reduce out-of-pocket costs. medpac comment on cms's interim final rule on durable medical equipment fee schedule adjustments. sign up to recieve e-mail notices of commission meetings and new posts to our website.